India 2011 © Anna Surinyach/MSF
A 30-year-old patient receives treatment for post-kala azar dermal leishmanisasis (PKDL), an infection some patients contract after being treated for kala azar, mainly in India and Bangladesh. Although PKDL is relatively painless, it is a reservoir for the kala azar parasite and it must be treated to prevent the disease from spreading.